Category: India
-
Delhi High Court orders Transsion to pay pro tem security to InterDigital
âGranting pro tem security balances the asymmetric advantage that an implementer has over an SEP holder,â the court emphasized in its judgment.
-
Nokia, ASUS ink patent licensing deal: will also arbitrate terms
Nokia has now settled the last of its three global disputes targeting major implementers over video patent infringement, signing a patent license agreement with ASUS. The terms of the deal will be determined through arbitration.
-
Delhi High Court overturns Philipsâ DVD SEP win, finds âinsufficient evidenceâ of essentiality or infringement, narrows royalty base
The Delhi High Court appellate bench has reversed Philips’s landmark DVD SEP win, finding no proof of essentiality, infringement, or FRAND rates. The exhaustion defense saves the defendant.
-
Delhi High Court orders Xiaomi to deposit $28.7 million in Malikie SEP dispute, cites Shenzhen FRAND case as potential admission
The Delhi High Court directed Xiaomi to deposit âš272 crores ($28.7 million) as pro tem security in a SEP dispute with Malikie, treating Xiaomi’s parallel FRAND filing in China as a prima facie admission of essentiality.
-
Delhi High Court orders Rosenberger to pay $17.7 million in damages, upholds rival antenna patent
Delhi High Court has awarded Canadian antenna maker CCA $17.7 million in a patent infringement suit against German antenna maker Rosenberger on the 13th anniversary of the Novartis ruling. The decision sets comparable royalties as the standard for damages and employed live transcription for the first time in an Indian patent trial.
-
Another semaglutide generic enters India as Novo Nordisk patent expires, no injunction issuesÂ
The Delhi High Court has issued a ruling allowing a generic version of semaglutide to be sold without an injunction and indicating a cautious approach to late-stage enforcement, favoring restricted entry over exclusion, by basing it around a contested claim limitation.
-
Novo Nordisk settles U.S. semaglutide patent infringement dispute, but denied Indian interim injunction again
While Novo Nordisk has struck an agreement with U.S. telehealth platform Hims & Hers to sell Ozempic and Wegovy, the Delhi High Court has once again denied its request for an interim injunction against Dr. Reddyâs Laboratories to block its sales of semaglutide products after its patent expires in 10 days.
-
InterDigital files patent infringement actions against Hisense, TCL in UPC, Germany, Brazil, India; TCL also in U.S.
InterDigital has a very successful licensing program and needs to litigate only in a minority of cases. Launching enforcement actions in four (TCL: five) jurisdictions in parallel is a strong statement.
-
Delhi HC upholds interim injunction over Canvaâs âPresent and Recordâ feature
A Division Bench ruling affirmed an earlier single-judge decision.